ECSP024363A - REPLACED 1-AMINOALQUIL-LACTAMAS AND ITS USE AS ANTAGONIST OF MUSCARINIC RECEPTORS - Google Patents

REPLACED 1-AMINOALQUIL-LACTAMAS AND ITS USE AS ANTAGONIST OF MUSCARINIC RECEPTORS

Info

Publication number
ECSP024363A
ECSP024363A EC2002004363A ECSP024363A ECSP024363A EC SP024363 A ECSP024363 A EC SP024363A EC 2002004363 A EC2002004363 A EC 2002004363A EC SP024363 A ECSP024363 A EC SP024363A EC SP024363 A ECSP024363 A EC SP024363A
Authority
EC
Ecuador
Prior art keywords
muscarinic receptors
aminoalquil
lactamas
antagonist
replaced
Prior art date
Application number
EC2002004363A
Other languages
Spanish (es)
Inventor
Robert J Weikert
Russell Stephen Stabler
Ann Marie Madera
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ECSP024363A publication Critical patent/ECSP024363A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Esta invención se refiere a compuestos que son generalmente antagonistas de los receptores muscarínicos M2/M3 y que están generalmente por la fórmula en donde X;Y y Z son -O-, -8- 0>N-R4 y los demás sustituyentes tienen los significados definidos en la especificación; o "profarmacos", isomeros individuales, mezclas racemicas o no racemicas de isomeros, y sales farmacéuticamente aceptables o solvatos de los mismos. La invención se refiere además a composiciones farmacéuticas que contienen tales compuestos, a un proceso para su obtención y a su utilización para el tratamiento de enfermedades asociadas con trastornos del músculo liso.This invention relates to compounds that are generally antagonists of M2 / M3 muscarinic receptors and that are generally by the formula wherein X; Y and Z are -O-, -8- 0> N-R4 and the other substituents have the meanings defined in the specification; or "prodrugs", individual isomers, racemic or non-racemic mixtures of isomers, and pharmaceutically acceptable salts or solvates thereof. The invention further relates to pharmaceutical compositions containing such compounds, a process for obtaining them and their use for the treatment of diseases associated with smooth muscle disorders.

EC2002004363A 2000-05-25 2002-11-25 REPLACED 1-AMINOALQUIL-LACTAMAS AND ITS USE AS ANTAGONIST OF MUSCARINIC RECEPTORS ECSP024363A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20748300P 2000-05-25 2000-05-25

Publications (1)

Publication Number Publication Date
ECSP024363A true ECSP024363A (en) 2003-03-31

Family

ID=32849292

Family Applications (2)

Application Number Title Priority Date Filing Date
EC2002004363A ECSP024363A (en) 2000-05-25 2002-11-25 REPLACED 1-AMINOALQUIL-LACTAMAS AND ITS USE AS ANTAGONIST OF MUSCARINIC RECEPTORS
EC2002004362A ECSP024362A (en) 2000-05-25 2002-11-25 REPLACED 1-AMINOALQUIL-LACTAMAS AND ITS USE AS ANTAGONIST OF MUSCARINIC RECEPTORS

Family Applications After (1)

Application Number Title Priority Date Filing Date
EC2002004362A ECSP024362A (en) 2000-05-25 2002-11-25 REPLACED 1-AMINOALQUIL-LACTAMAS AND ITS USE AS ANTAGONIST OF MUSCARINIC RECEPTORS

Country Status (2)

Country Link
EC (2) ECSP024363A (en)
ZA (2) ZA200208895B (en)

Also Published As

Publication number Publication date
ZA200209029B (en) 2004-02-06
ZA200208895B (en) 2004-02-19
ECSP024362A (en) 2003-03-31

Similar Documents

Publication Publication Date Title
AR033377A1 (en) DERIVATIVES OF BENZOCICLOALQUILENILAMINA AS ANTAGONISTS OF MUSCARINIC RECEPTORS
UY26729A1 (en) HETEROCYCLIC ALKYLAMINES AS ANTAGONISTS OF MUSCARINIC RECEPTORS
ES2158814B1 (en) PIRROLIDINE DERIVATIVES ANTAGONIST RECEIVER CCR-3
PA8580301A1 (en) NEW BENZOIMIDAZOL DERIVATIVES USEFUL AS ANTIPROLIFERATIVE AGENTS
HK1120725A1 (en) Tetrahydro-beta-carbolin-sulfonamide derivatives as 5-ht6ligands
UY28026A1 (en) 4-PIPERAZINILBENCENOSULFONILINDOLES AND USES OF THE SAME.
ECSP066391A (en) [1,8] NAFTIRIDIN-2-ONAS AND RELATED COMPOUNDS FOR THE TREATMENT OF CHICHOPHRENIA
UY28135A1 (en) PIRIMIDINE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELLULAR GROWTH
UY29412A1 (en) N-SULFONYLAMINOFENILETIL-2-PHENOXYACETAMIDE SUBSTITUTED COMPOUNDS.
UY27322A1 (en) NEW INDOL DERIVATIVES WITH AFFINITY FOR THE 5-HT6 RECEIVER
PA8575401A1 (en) DERIVATIVES OF BENZOCONDENSED HETEROARILAMIDE OF USEFUL TIENOPIRIDINS AS THERAPEUTIC AGENTS, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THE SAME AND METHODS FOR USE
PA8547901A1 (en) 4-PIPERACINYLINDOL DERIVATIVES WITH 5-HT6 RECEPTOR AFFINITY
UY28105A1 (en) INDAZOL DERIVATIVES AS CRF ANTAGONISTS
ES2179353T3 (en) MUSCARINIC ANTAGONISTS.
ECSP056192A (en) 3-FLUORO-PIPERIDINS AS ANTAGONISTS OF NMDA / NR2B
ECSP088967A (en) MUSCARINIC RECEIVER AGONISTS THAT ARE EFFECTIVE IN THE TREATMENT OF PAIN, ALZHEIMER'S DISEASE AND SCHIZOPHRENIA
UY27023A1 (en) FENYL KETON DERIVATIVES REPLACED AS IP ANTAGONISTS
UY30398A1 (en) "USE OF CGRP ANTAGONISTS (A), THEIR ENANTINMEROS, DIASTERNMEROS, MIXTURES AND PHARMACUTICALLY ACCEPTABLE SALTS TO PREPARE MEDICINES, AND COMPOSITIONS THAT CONTAIN THEM"
UY26919A1 (en) DERIVATIVES OF QUINAZOLINE AS ALFA ADRENERGIC ANTAGONISTS - 1
UY27685A1 (en) INDOLIL-UREA DERIVED FROM USEFUL TIENOPIRIDINS AS ANTIANGIOGEN AGENTS, AND PROCEDURES FOR USE
CO5611124A2 (en) BENZOFURAN DERIVATIVES SUBSTITUTED USEFUL IN THE TREATMENT OF HYPER-PROLIFERATIVE DISORDERS
UY29733A1 (en) ACETYLENE PIPERAZINS AS ANTAGONISTS OF METABOTROPIC GLUTAMATE RECEPTORS
PA8540601A1 (en) DERIVATIVES OF ALCOXICARBONILAMINOTETRAZOLIL PHENYLL OR BENZOIC ALCOXICARBONYLAMINE ACID AS IP ANTAGONISTS
ECSP024363A (en) REPLACED 1-AMINOALQUIL-LACTAMAS AND ITS USE AS ANTAGONIST OF MUSCARINIC RECEPTORS
MXPA05011476A (en) Imidazolin-2-ylaminophenyl amides as ip antagonists.